7136 Randomized, placebo-controlled, phase 3 study of everolimus, a novel therapy for patients with metastatic renal cell carcinoma: subgroup analysis of patients progressing on prior bevacizumab therapy

✍ Scribed by Hutson, T.; Negrier, S.; Kay, A.

• Book ID: 123240773
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 47 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71469-7